Zobrazeno 1 - 10
of 4 466
pro vyhledávání: '"Ros1"'
Publikováno v:
Urban Lifeline, Vol 2, Iss 1, Pp 1-20 (2024)
Abstract The research on multi-robot systems has been divided into various fields, such as communication, navigation, task allocation, and collaborative transport. While significant progress has been made in each area, there has been limited research
Externí odkaz:
https://doaj.org/article/7e212a93bcd34552bad9587617e4225b
Autor:
Urska Janzic, Natalie Maimon Rabinovich, Walid Shalata, Waleed Kian, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopovic, Giannis Mountzios, Adam Pluzanski, Antonio Araujo, Andriani Charpidou, Sameh Daher, Abed Agbarya
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4369-4381 (2024)
ROS1 rearrangements are considered rare in non-small-cell lung cancer (NSCLC). This retrospective real-world study aimed to evaluate first-line treatment with crizotinib, a tyrosine kinase inhibitor (TKI) standard of care vs. new generation ROS1 anti
Externí odkaz:
https://doaj.org/article/adb21f604fcc4328811acd70c304e952
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 781-789 (2024)
Alvaro Osorio,1,2 Liliana Fernandez-Trujillo,2,3 Juan G Restrepo,1,2 Luz F Sua,2,4 Catalina Proaño,5 Valeria Zuñiga-Restrepo2 1Department of Internal Medicine, Oncology Service, Fundación Valle Del Lili, Cali, Colombia; 2Faculty of Health Sciences
Externí odkaz:
https://doaj.org/article/92ad0eda539f40b6a530324f2e803abc
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionThe transcriptomic characteristics of ROS1+ non-small cell lung cancer (NSCLC) represent a crucial aspect of its tumor biology. These features provide valuable insights into key dysregulated pathways, potentially leading to the discovery
Externí odkaz:
https://doaj.org/article/637c8e9766304bc6b3531fafa69882fb
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 10, Pp n/a-n/a (2024)
Abstract The ROS1 proto‐oncogene encodes a receptor tyrosine kinase with structural homology to other oncogenic drivers, including ALK and TRKA‐B‐C. The FDA‐approved tyrosine kinase inhibitors (TKIs) crizotinib and entrectinib have demonstrat
Externí odkaz:
https://doaj.org/article/b3703d2d6ea4452c8c1316b4b0921905
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/99adb6ee4377419d9ad4b8250b90bb2b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anjali Murali, Anju Farsana A, Sobha Subramaniam, Malini Eapen, Indu R. Nair, Keechilat Pavithran
Publikováno v:
Respirology Case Reports, Vol 12, Iss 9, Pp n/a-n/a (2024)
Abstract Non‐small‐cell lung cancer (NSCLC) accounts for the majority of lung cancer cases worldwide, with a significant proportion of patients harbouring actionable oncogenic alterations. Among these alterations, the ROS1 rearrangement represent
Externí odkaz:
https://doaj.org/article/e576f169d0914bc996d0df38edd7efcd
Autor:
Ariel R. Choi, Ralph B. D’Agostino, Michael K. Farris, Mohammed Abdulhaleem, John C. Hunting, Yuezhu Wang, Margaret R. Smith, Jimmy Ruiz, Thomas W. Lycan, W. Jeffrey Petty, Christina K. Cramer, Stephen B. Tatter, Adrian W. Laxton, Jaclyn J. White, Wencheng Li, Jing Su, Christopher Whitlow, Fei Xing, Michael D. Chan
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Purpose/objective(s)Biomarkers for extracranial oligometastatic disease remain elusive and few studies have attempted to correlate genomic data to the presence of true oligometastatic disease.MethodsPatients with non-small cell lung cancer (NSCLC) an
Externí odkaz:
https://doaj.org/article/6364785a593e426591cfe97e0776e128
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 7, Pp 100673- (2024)
Repotrectinib, licensed in November 2023, is a novel ROS1 tyrosine kinase inhibitor (TKI) with activity against G2032R, the most common resistance mutation to prior generations of ROS1 TKIs. Here, we report a case of a patient who was heavily pretrea
Externí odkaz:
https://doaj.org/article/7431ea6377e4481c94bd50a8012202bb